Crossmark

High Oct4 expression: implications in the pathogenesis of neuroblastic tumours

Crossref DOI link: https://doi.org/10.1186/s12885-018-5219-3

Published Online: 2019-01-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Monferrer, Ezequiel

Burgos-Panadero, Rebeca

Blanquer-Maceiras, Maite

Cañete, Adela

Navarro, Samuel

Noguera, Rosa https://orcid.org/0000-0003-4546-7459
Funding

Funding for this research was provided by:

European Regional Development Fund (PI14/01008, PI17/01558)

CIBERONC (CB16/12/00484)

Fundación Científica Asociación Española Contra el Cáncer (FAECC2015/2016)

NEN Association

Neuroblastoma Foundation
License Information

Text and Data Mining valid from 2019-01-03
More Information

Article History

Received: 29 August 2018

Accepted: 13 December 2018

First Online: 3 January 2019

Ethics approval and consent to participate

: All patients, their relatives or their legal guardians signed the appropriate written informed consent. The present study was approved by INCLIVA’s Clinical Research Ethics Committee (ref. B.0000339).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.